IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-35835-3.html
   My bibliography  Save this article

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Author

Listed:
  • Kara W. Chew

    (David Geffen School of Medicine at University of California, Los Angeles)

  • Carlee Moser

    (Harvard T.H. Chan School of Public Health)

  • Eric S. Daar

    (Lundquist Institute at Harbor-UCLA Medical Center)

  • David A. Wohl

    (University of North Carolina at Chapel Hill School of Medicine)

  • Jonathan Z. Li

    (Brigham and Women’s Hospital, Harvard Medical School)

  • Robert W. Coombs

    (University of Washington
    University of Washington)

  • Justin Ritz

    (Harvard T.H. Chan School of Public Health)

  • Mark Giganti

    (Harvard T.H. Chan School of Public Health)

  • Arzhang Cyrus Javan

    (National Institutes of Health)

  • Yijia Li

    (Brigham and Women’s Hospital, Harvard Medical School
    University of Pittsburgh)

  • Manish C. Choudhary

    (Brigham and Women’s Hospital, Harvard Medical School)

  • Rinki Deo

    (Brigham and Women’s Hospital, Harvard Medical School)

  • Carlos Malvestutto

    (Ohio State University Wexner Medical Center)

  • Paul Klekotka

    (Eli Lilly and Company)

  • Karen Price

    (Eli Lilly and Company)

  • Ajay Nirula

    (Eli Lilly and Company)

  • William Fischer

    (University of North Carolina at Chapel Hill School of Medicine)

  • Veenu Bala

    (University of Nebraska Medical Center
    Clinical Pharmacology & Pharmacometrics, Jounce Therapeutics)

  • Ruy M. Ribeiro

    (Los Alamos National Laboratory)

  • Alan S. Perelson

    (Los Alamos National Laboratory)

  • Courtney V. Fletcher

    (University of Nebraska Medical Center)

  • Joseph J. Eron

    (University of North Carolina at Chapel Hill School of Medicine)

  • Judith S. Currier

    (David Geffen School of Medicine at University of California, Los Angeles)

  • Michael D. Hughes

    (Harvard T.H. Chan School of Public Health)

  • Davey M. Smith

    (University of California, San Diego)

Abstract

No abstract is available for this item.

Suggested Citation

  • Kara W. Chew & Carlee Moser & Eric S. Daar & David A. Wohl & Jonathan Z. Li & Robert W. Coombs & Justin Ritz & Mark Giganti & Arzhang Cyrus Javan & Yijia Li & Manish C. Choudhary & Rinki Deo & Carlos , 2023. "Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19," Nature Communications, Nature, vol. 14(1), pages 1-1, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-35835-3
    DOI: 10.1038/s41467-023-35835-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-35835-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-35835-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-35835-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.